According to Perrigo's latest financial reports and stock price the company's current number of shares outstanding is 135,500,000. At the end of 2023 the company had 135,500,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.13 B | 0.67% |
2022 | 0.13 B | 0.6% |
2021 | 0.13 B | -1.98% |
2020 | 0.13 B | 0.37% |
2019 | 0.13 B | -1.02% |
2018 | 0.13 B | -2.76% |
2017 | 0.14 B | -1.4% |
2016 | 0.14 B | -2.05% |
2015 | 0.14 B | 7.34% |
2014 | 0.13 B | 38.1% |
2013 | 98.7 M | 5.11% |
2012 | 93.9 M | 0.73% |
2011 | 93.22 M | 1.07% |
2010 | 92.23 M | 0.65% |
2009 | 91.63 M | -0.45% |
2008 | 92.04 M | -1.18% |
2007 | 93.14 M | 1.43% |
2006 | 91.83 M | -1.07% |
2005 | 92.83 M | 30.37% |
2004 | 71.2 M | 1.77% |
2003 | 69.96 M | 1% |
2002 | 69.27 M | -5.55% |
2001 | 73.34 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
United Therapeutics UTHR | 47,000,000 | -65.31% | ๐บ๐ธ USA |
Endo International
ENDPQ | 235,220,000 | 73.59% | ๐ฎ๐ช Ireland |
Intercept Pharmaceuticals
ICPT | 41,792,000 | -69.16% | ๐บ๐ธ USA |
Catalent CTLT | 182,000,000 | 34.32% | ๐บ๐ธ USA |